Impact of SARS-CoV-2 (COVID-19) Infection, Treated in Ambulatory Care, on Long-term Quality of Life in a Parisian Military Population
NCT ID: NCT04893070
Last Updated: 2022-10-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
173 participants
OBSERVATIONAL
2021-07-15
2022-07-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
COVID-19 Infection in Healthcare Workers
NCT04386759
Perceived Health After Hospitalization for COVID-19
NCT04912804
Identifying Functional and Psycho-social Complaints After Hospitalization for SARS-CoV-2 Infection( COVID 19)- REPERCOV
NCT04561154
COVID-19 Seroconversion Among Front Line Medical and Paramedical Staff in Emergency, Intensive Care Units and Infectious Disease Departments During the 2020 Epidemic
NCT04304690
Longitudinal Study of Covid-19 Infection Among HCW in a French University Hospital
NCT04362267
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
COVID+
Questionnaires on COVID-19 symptomatology and quality of life
Questionnaires COVID+
* 1 questionnaire on COVID-19 symptomatology and quality of life 12 months after COVID-19 first symptoms
* 1 questionnaire on quality of life 18 months after COVID-19 first symptoms
COVID-
Questionnaires on quality of life
Questionnaires COVID-
* 1 questionnaire on quality of life at enrollment
* 1 questionnaire on quality of life 6 months after enrollment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaires COVID+
* 1 questionnaire on COVID-19 symptomatology and quality of life 12 months after COVID-19 first symptoms
* 1 questionnaire on quality of life 18 months after COVID-19 first symptoms
Questionnaires COVID-
* 1 questionnaire on quality of life at enrollment
* 1 questionnaire on quality of life 6 months after enrollment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* COVID+: diagnosed with COVID-19 and managed in ambulatory care since March 14th, 2020
* COVID-: not having been infected with SARS-CoV-2
Exclusion Criteria
* Having received a treatment against COVID-19 (other than paracetamol)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Direction Centrale du Service de Santé des Armées
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
1er Centre Médical des Armées
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-A01038-33
Identifier Type: OTHER
Identifier Source: secondary_id
2020-COVID19-38
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.